Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 1,707 shares of Exponent stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $66.28, for a total transaction of $113,139.96. Following the sale, the chief executive officer owned 129,108 shares in the company, valued at $8,557,278.24. This represents a 1.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Catherine Corrigan also recently made the following trade(s):
- On Monday, June 15th, Catherine Corrigan sold 4,119 shares of Exponent stock. The shares were sold at an average price of $57.13, for a total transaction of $235,318.47.
Exponent Trading Up 2.0%
EXPO opened at $67.51 on Wednesday. The company has a fifty day simple moving average of $62.15 and a 200 day simple moving average of $64.59. The firm has a market cap of $3.21 billion, a price-to-earnings ratio of 30.27 and a beta of 0.68. Exponent, Inc. has a twelve month low of $51.91 and a twelve month high of $81.95.
Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.55 by $0.05. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The firm had revenue of $171.61 million for the quarter, compared to the consensus estimate of $144.99 million. During the same quarter in the previous year, the firm posted $0.52 EPS. The firm's quarterly revenue was up 12.0% on a year-over-year basis. On average, analysts forecast that Exponent, Inc. will post 2.31 earnings per share for the current fiscal year.
Exponent Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, September 4th. Exponent's payout ratio is presently 55.61%.
Institutional Investors Weigh In On Exponent
Several hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in shares of Exponent in the 2nd quarter valued at about $363,428,000. Conestoga Capital Advisors LLC grew its stake in Exponent by 1.3% in the fourth quarter. Conestoga Capital Advisors LLC now owns 2,392,499 shares of the business services provider's stock worth $166,183,000 after purchasing an additional 31,303 shares in the last quarter. Morgan Stanley increased its holdings in Exponent by 3.6% in the fourth quarter. Morgan Stanley now owns 1,154,210 shares of the business services provider's stock valued at $80,172,000 after buying an additional 39,865 shares during the last quarter. First Trust Advisors LP increased its holdings in Exponent by 7.4% in the first quarter. First Trust Advisors LP now owns 964,814 shares of the business services provider's stock valued at $62,954,000 after buying an additional 66,471 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Exponent by 2.3% during the first quarter. Dimensional Fund Advisors LP now owns 918,885 shares of the business services provider's stock valued at $59,958,000 after buying an additional 20,270 shares in the last quarter. Institutional investors own 92.37% of the company's stock.
Analyst Upgrades and Downgrades
EXPO has been the subject of a number of analyst reports. JPMorgan Chase & Co. increased their price target on Exponent from $80.00 to $90.00 and gave the company an "overweight" rating in a report on Friday, July 31st. UBS Group set a $72.00 target price on Exponent and gave the company a "neutral" rating in a research report on Friday, July 31st. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Exponent in a research note on Friday, July 17th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $81.00.
View Our Latest Research Report on EXPO
Exponent Company Profile
(
Get Free Report)
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company's expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
